NCT05640037

Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 99 (actual)
• Sponsor: Zhongnan Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study aims to evaluate the efficacy of IL-37 as a biomarker to predict mortality risk in adults with sepsis.

Detailed description

Sepsis patients admitted in the Department of Critical Care Medicine, Zhongnan Hospital will be included. There are three groups of patients in this study: control group, sepsis group and septic shock group. The interleukin-37 (IL-37) concentration in urine was analyzed in the day 1, 2, 4, 6. Additionally, IL-37 concentration between blood stream infection groups and non-infection groups were analyzed. IL-37 concentration between survivors and non-survivors were also compared. IL-37 concentration were followed from day 1, 2, 4, 6.The correlation between the concentration of IL-37, IL-1β, IL-6、IL-10 and TNF-α were analyzed. Furthermore, the investigators will determine the correlation between the concentration of IL-37, sepsis associated organ dysfunction, 28-day mortality. Lastly, the predictive value of IL-37 to sepsis associated organ dysfunction and prognosis were explored.

Conditions

• Sepsis

Timeline

• Start date: 2022-03-23
• Primary completion: 2024-03-20
• Completion: 2024-03-20
• First posted: 2022-12-07
• Last updated: 2024-05-08

Locations

1 site across 1 country: China